Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study. - Wu Y; Zhou Y; Yin W; Zhao X; Xu L; Su Y; Wang S; Li S; Wang Y; Duan C; Fang Y; Meng Z (Frontiers in immunology, 2026)